Skip to main content
Top
Published in: Strahlentherapie und Onkologie 11/2012

01-11-2012 | Original article

Late complications after radiotherapy for prostate cancer

Authors: Prof. Dr. H. Jung, H.-P. Beck-Bornholdt, V. Svoboda, W. Alberti, T. Herrmann

Published in: Strahlentherapie und Onkologie | Issue 11/2012

Login to get access

Abstract

Background

The aim of the present study was to analyze in detail the time course of the incidence of radiation-induced late effects. For this purpose, unpublished data of patients treated by radiation therapy in Hamburg in the late 1980s were analyzed. Relatively large volumes were exposed to comparatively high doses, thus leading to a high rate of treatment-related side effects.

Patients and methods

A total of 180 consecutive patients received radiotherapy for prostate cancer. The median age was 66 years (range 41–88 years). The median of the maximum dose was 77.5 Gy (range 56.3–95 Gy) and overall treatment time was 51 days (range 28–128 days). Endpoints analyzed were late complications of grade 3 or higher, overall and disease-free survival, local tumor control, and distant metastases. Data analysis was actuarial and the log-rank test was used to compare the various subgroups.

Results

After 2 years, 80.5 ± 3.2% of the patients were without any complications of grade 3 or higher, and after 5 years a constant level of 70.3 ± 4.0% was approached. When multiple lesions occurred per patient, the later events were disregarded. A total of 66 complications occurred in 42 patients. The percentage of patients being free from late complications, plotted as a function of time after start of radiation therapy, was adequately described by an exponential function and a constant fraction. Complications approached a constant level of 70.3% at a rate of 5.3% per month. This means that patients who will develop a complication do so at exponential kinetics and at a relatively high rate, whereas about 70% of the patients will never experience a late effect even over long observation periods. After subdividing the maximum dose into three equal dose groups of 55 patients each (< 73.3 Gy, 73.3–80 Gy, > 80 Gy), the constant fraction decreased from 85.7 to 72.8% and 52.2%, whereas the incidence rate was 4.3%, 7.7%, and 5.6% per month and, thus, almost independent of radiation dose.

Conclusion

For a given group of patients, the rate of the incidence of late complications appears to be independent of radiation dose and (from analyzing data in the literature) independent of the grade of lesions, whereas the fraction of patients without late effects depends on both parameters.
Literature
1.
go back to reference Alicikus ZA, Yamada Y, Zhang Z et al (2011) Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 117:1429–1437PubMedCrossRef Alicikus ZA, Yamada Y, Zhang Z et al (2011) Ten-year outcomes of high-dose, intensity-modulated radiotherapy for localized prostate cancer. Cancer 117:1429–1437PubMedCrossRef
2.
go back to reference Dibiase SJ, Hussain A, Kataria R et al (2011) Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys 81:732–736PubMedCrossRef Dibiase SJ, Hussain A, Kataria R et al (2011) Long-term results of a prospective, Phase II study of long-term androgen ablation, pelvic radiotherapy, brachytherapy boost, and adjuvant docetaxel in patients with high-risk prostate cancer. Int J Radiat Oncol Biol Phys 81:732–736PubMedCrossRef
3.
go back to reference Huang EH, Polack A, Levy L et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314–1321PubMedCrossRef Huang EH, Polack A, Levy L et al (2002) Late rectal toxicity: dose-volume effects of conformal radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys 54:1314–1321PubMedCrossRef
4.
go back to reference Jereczek-Fossa B, Jassem J, Nowak R, Badzio A (1998) Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model. Int J Radiat Oncol Biol Phys 41:329–338PubMedCrossRef Jereczek-Fossa B, Jassem J, Nowak R, Badzio A (1998) Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model. Int J Radiat Oncol Biol Phys 41:329–338PubMedCrossRef
5.
go back to reference Jung H, Beck-Bornholdt H-P, Svoboda V et al (2001) Quantification of late complications after radiation therapy. Radiother Oncol 61:233–246PubMedCrossRef Jung H, Beck-Bornholdt H-P, Svoboda V et al (2001) Quantification of late complications after radiation therapy. Radiother Oncol 61:233–246PubMedCrossRef
6.
go back to reference Kim S, Shen S, Moore DF et al (2011) Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol 60:908–916PubMedCrossRef Kim S, Shen S, Moore DF et al (2011) Late gastrointestinal toxicities following radiation therapy for prostate cancer. Eur Urol 60:908–916PubMedCrossRef
7.
go back to reference Langsenlehner T, Renner W, Gerger A et al (2011) Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlenther Onkol 187:784–791PubMedCrossRef Langsenlehner T, Renner W, Gerger A et al (2011) Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients. Strahlenther Onkol 187:784–791PubMedCrossRef
8.
go back to reference Michalski JM, Bae K, Roach M et al (2010) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys 76:14–22PubMedCrossRef Michalski JM, Bae K, Roach M et al (2010) Long-term toxicity following 3D conformal radiation therapy for prostate cancer from the RTOG 9406 phase I/II dose escalation study. Int J Radiat Oncol Biol Phys 76:14–22PubMedCrossRef
9.
go back to reference Mohammed N, Kestin L, Ghilezan M et al (2012) Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys 82:204–412PubMedCrossRef Mohammed N, Kestin L, Ghilezan M et al (2012) Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer. Int J Radiat Oncol Biol Phys 82:204–412PubMedCrossRef
10.
go back to reference Pedersen D, Bentzen SM, Overgaard J (1994) Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29:941–952PubMedCrossRef Pedersen D, Bentzen SM, Overgaard J (1994) Early and late radiotherapeutic morbidity in 442 consecutive patients with locally advanced carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 29:941–952PubMedCrossRef
11.
go back to reference Roberts SA, Hendry JH, Swindell R et al (2004) Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomized trial. Radiother Oncol 70:63–74PubMedCrossRef Roberts SA, Hendry JH, Swindell R et al (2004) Compensation for changes in dose-rate in radical low-dose-rate brachytherapy: a radiobiological analysis of a randomized trial. Radiother Oncol 70:63–74PubMedCrossRef
12.
go back to reference Sharma NK, Li T, Chen DY et al (2011) Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 80:437–444PubMedCrossRef Sharma NK, Li T, Chen DY et al (2011) Intensity-modulated radiotherapy reduces gastrointestinal toxicity in patients treated with androgen deprivation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 80:437–444PubMedCrossRef
13.
go back to reference Skwarchuk MW, Jackson A, Zelefsky MJ et al (2000) Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47:103–113PubMedCrossRef Skwarchuk MW, Jackson A, Zelefsky MJ et al (2000) Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys 47:103–113PubMedCrossRef
14.
go back to reference Svoboda V, Beck-Bornholdt H-P, Herrmann T et al (1999) Late complications after a combined pre and postoperative (sandwich) radiotherapy for rectal cancer. Radiother Oncol 53:177–187PubMedCrossRef Svoboda V, Beck-Bornholdt H-P, Herrmann T et al (1999) Late complications after a combined pre and postoperative (sandwich) radiotherapy for rectal cancer. Radiother Oncol 53:177–187PubMedCrossRef
15.
go back to reference Tucker SL, Dong L, Michalski JM et al (2012) Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from Radiation Therapy Oncology Group Protocol 94–06. Int J Radiat Oncol Biol Phys (In press) Tucker SL, Dong L, Michalski JM et al (2012) Do intermediate radiation doses contribute to late rectal toxicity? An analysis of data from Radiation Therapy Oncology Group Protocol 94–06. Int J Radiat Oncol Biol Phys (In press)
16.
go back to reference Vesprini D, Sia M, Lockwood G et al (2011) Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 81:415–421CrossRef Vesprini D, Sia M, Lockwood G et al (2011) Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 81:415–421CrossRef
17.
go back to reference Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy für prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116PubMedCrossRef Zelefsky MJ, Fuks Z, Hunt M et al (2002) High-dose intensity modulated radiation therapy für prostate cancer: early toxicity and biochemical outcome in 772 patients. Int J Radiat Oncol Biol Phys 53:1111–1116PubMedCrossRef
Metadata
Title
Late complications after radiotherapy for prostate cancer
Authors
Prof. Dr. H. Jung
H.-P. Beck-Bornholdt
V. Svoboda
W. Alberti
T. Herrmann
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Strahlentherapie und Onkologie / Issue 11/2012
Print ISSN: 0179-7158
Electronic ISSN: 1439-099X
DOI
https://doi.org/10.1007/s00066-012-0142-z

Other articles of this Issue 11/2012

Strahlentherapie und Onkologie 11/2012 Go to the issue

Mitteilungen der Fachgesellschaften

Mitteilungen